Analysis of the influence of recent reforms in China

Cardiovascular and cerebrovascular medicines as a case history to provide future direction

Wenjie Zeng, Junjie Zhen, Mengying Feng, Stephen Campbell, Alexander Finlayson, Brian Godman

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background: Pharmaceutical expenditure has grown by 16% per annum in China, enhanced by incentives for physicians and hospitals. Hospital pharmacies dispense 80% of medicines in China, accounting for 46% of total hospital expenditure. Principal measures to moderate drug expenditure growth include pricing initiatives as limited demand-side measures. Objective: Assess current utilization and expenditure including traditional Chinese medicines (TCMs) between 2006 and 2012. Methods: Uncontrolled retrospective study of medicines to treat cardiovascular and cerebrovascular diseases in one of the largest hospitals in southwest China. Results: Utilization increased 3.3-fold for cerebrovascular medicines, greatest for TCMs, with expenditure increasing 4.85-fold. Low prices for generics were seen, similar to Europe. However, there was variable utilization of generics at 29-31% of total product volumes in recent years. There continued to be irrationality in prescribing with high use of TCMs, and the utilization of different medicines dropping significantly once they achieved low prices. Conclusion: Prices still have an appreciable impact on utilization in China. Potential measures similar to those implemented among western European countries could improve prescribing rationality and conserve resources.

Original languageEnglish
Pages (from-to)371-386
Number of pages16
JournalJournal of Comparative Effectiveness Research
Volume3
Issue number4
DOIs
Publication statusPublished - 2014
Externally publishedYes

Fingerprint

Health Expenditures
China
Chinese Traditional Medicine
Cerebrovascular Disorders
Pharmacies
Pharmaceutical Preparations
Motivation
Cardiovascular Diseases
Retrospective Studies
Direction compound
Physicians
Costs and Cost Analysis
Growth

Cite this

Zeng, Wenjie ; Zhen, Junjie ; Feng, Mengying ; Campbell, Stephen ; Finlayson, Alexander ; Godman, Brian. / Analysis of the influence of recent reforms in China : Cardiovascular and cerebrovascular medicines as a case history to provide future direction. In: Journal of Comparative Effectiveness Research. 2014 ; Vol. 3, No. 4. pp. 371-386.
@article{ed22114be130464d8430182172517962,
title = "Analysis of the influence of recent reforms in China: Cardiovascular and cerebrovascular medicines as a case history to provide future direction",
abstract = "Background: Pharmaceutical expenditure has grown by 16{\%} per annum in China, enhanced by incentives for physicians and hospitals. Hospital pharmacies dispense 80{\%} of medicines in China, accounting for 46{\%} of total hospital expenditure. Principal measures to moderate drug expenditure growth include pricing initiatives as limited demand-side measures. Objective: Assess current utilization and expenditure including traditional Chinese medicines (TCMs) between 2006 and 2012. Methods: Uncontrolled retrospective study of medicines to treat cardiovascular and cerebrovascular diseases in one of the largest hospitals in southwest China. Results: Utilization increased 3.3-fold for cerebrovascular medicines, greatest for TCMs, with expenditure increasing 4.85-fold. Low prices for generics were seen, similar to Europe. However, there was variable utilization of generics at 29-31{\%} of total product volumes in recent years. There continued to be irrationality in prescribing with high use of TCMs, and the utilization of different medicines dropping significantly once they achieved low prices. Conclusion: Prices still have an appreciable impact on utilization in China. Potential measures similar to those implemented among western European countries could improve prescribing rationality and conserve resources.",
keywords = "China, cardiovascular drugs, demand-side measures, drug utilization, generics",
author = "Wenjie Zeng and Junjie Zhen and Mengying Feng and Stephen Campbell and Alexander Finlayson and Brian Godman",
year = "2014",
doi = "10.2217/cer.14.28",
language = "English",
volume = "3",
pages = "371--386",
journal = "Journal of Comparative Effectiveness Research",
issn = "2042-6305",
publisher = "Future Medicine Ltd",
number = "4",

}

Analysis of the influence of recent reforms in China : Cardiovascular and cerebrovascular medicines as a case history to provide future direction. / Zeng, Wenjie; Zhen, Junjie; Feng, Mengying; Campbell, Stephen; Finlayson, Alexander; Godman, Brian.

In: Journal of Comparative Effectiveness Research, Vol. 3, No. 4, 2014, p. 371-386.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Analysis of the influence of recent reforms in China

T2 - Cardiovascular and cerebrovascular medicines as a case history to provide future direction

AU - Zeng, Wenjie

AU - Zhen, Junjie

AU - Feng, Mengying

AU - Campbell, Stephen

AU - Finlayson, Alexander

AU - Godman, Brian

PY - 2014

Y1 - 2014

N2 - Background: Pharmaceutical expenditure has grown by 16% per annum in China, enhanced by incentives for physicians and hospitals. Hospital pharmacies dispense 80% of medicines in China, accounting for 46% of total hospital expenditure. Principal measures to moderate drug expenditure growth include pricing initiatives as limited demand-side measures. Objective: Assess current utilization and expenditure including traditional Chinese medicines (TCMs) between 2006 and 2012. Methods: Uncontrolled retrospective study of medicines to treat cardiovascular and cerebrovascular diseases in one of the largest hospitals in southwest China. Results: Utilization increased 3.3-fold for cerebrovascular medicines, greatest for TCMs, with expenditure increasing 4.85-fold. Low prices for generics were seen, similar to Europe. However, there was variable utilization of generics at 29-31% of total product volumes in recent years. There continued to be irrationality in prescribing with high use of TCMs, and the utilization of different medicines dropping significantly once they achieved low prices. Conclusion: Prices still have an appreciable impact on utilization in China. Potential measures similar to those implemented among western European countries could improve prescribing rationality and conserve resources.

AB - Background: Pharmaceutical expenditure has grown by 16% per annum in China, enhanced by incentives for physicians and hospitals. Hospital pharmacies dispense 80% of medicines in China, accounting for 46% of total hospital expenditure. Principal measures to moderate drug expenditure growth include pricing initiatives as limited demand-side measures. Objective: Assess current utilization and expenditure including traditional Chinese medicines (TCMs) between 2006 and 2012. Methods: Uncontrolled retrospective study of medicines to treat cardiovascular and cerebrovascular diseases in one of the largest hospitals in southwest China. Results: Utilization increased 3.3-fold for cerebrovascular medicines, greatest for TCMs, with expenditure increasing 4.85-fold. Low prices for generics were seen, similar to Europe. However, there was variable utilization of generics at 29-31% of total product volumes in recent years. There continued to be irrationality in prescribing with high use of TCMs, and the utilization of different medicines dropping significantly once they achieved low prices. Conclusion: Prices still have an appreciable impact on utilization in China. Potential measures similar to those implemented among western European countries could improve prescribing rationality and conserve resources.

KW - China

KW - cardiovascular drugs

KW - demand-side measures

KW - drug utilization

KW - generics

UR - http://www.scopus.com/inward/record.url?scp=84907816151&partnerID=8YFLogxK

UR - http://www.mendeley.com/research/analysis-influence-recent-reforms-china-cardiovascular-cerebrovascular-medicines-case-history-provid-1

U2 - 10.2217/cer.14.28

DO - 10.2217/cer.14.28

M3 - Article

VL - 3

SP - 371

EP - 386

JO - Journal of Comparative Effectiveness Research

JF - Journal of Comparative Effectiveness Research

SN - 2042-6305

IS - 4

ER -